Study

Trial design

Patient population

n =

Cooling method

Target temp

Cooling time

Primary Endpoint

Secondary Endpoint

Reperfusion therapy

Results

Dixon et al., 2002 11

Prospective RCT

STEMI within 6 hrs of onset

42

Endovascular catheter

33°C

4 hours

MACE at 30 days

Infarct size at 30 days *

Primary PCI

Non-significant decrease in MACE and infarct size

COOL MI
O'Neill et al., 2003 12

Prospective RCT

STEMI within 6 hrs of onset

357

Endovascular catheter

33°C

n/a

Infarct size and MACE at 30 days *

ST segment resolution, LVEF,
CK-MB and myoglobin release

Primary PCI

No difference in MACE or infarct size
Non-significant reduction in infarct size with anterior MI ‡

COOL MI II
Carrozza et al., 2005 45

Prospective RCT

Anterior STEMI within 6 hrs of onset

n/a

Endovascular catheter

33°C

n/a

Infarct size *
Safety profile

Infarct size,
ST segment resolution, LVEF †

Primary PCI

Trial halted prior to completion due to funding reasons

LOWTEMP
Kandzari et al., 2004 41

Feasibility cohort

STEMI within 6 hrs of onset

20

Endovascular catheter

32-34°C

4 hours

Infarct size at 30 days *,†

 

ST-segment resolution

Primary PCI

Feasible, associated with favorable safety, infarct size and ST-segment resolution outcomes

ICE-IT
Grines et al., 2004 13

Prospective RCT

Anterior or large inferior STEMI within 6 hrs of onset

228

Endovascular catheter

32-34°C

6 hours

Infarct size at 30 days *

n/a

Primary PCI

No difference in infarct size
Non-significant reduction in infarct size with anterior MI ‡

Hovdenes et al., 2007 53

Prospective observational

Comatose, VF- OHCA eligible for PCI

50

Cold NS infusion and external cooling

32-34°C

24 hours

Survival and neurological outcome at 6 months #

n/a

Primary or facilitated PCI

82% survival at 6 months
Larger infarct size in those with unfavorable neurological outcome †,‡

Wolfrum et al., 2008 48

Prospective observational with historical controls

Comatose, VF-OHCA with STEMI

33

Cold NS infusion and external cooling

32-34°C

24 hours

Survival and neurological outcome at 6 months #

n/a

Primary PCI

10% mortality reduction, improved neurological outcome
Non-significant reduction in infarct size with anterior MI ‡

Schefold et al., 2009 54

Prospective observational with historical controls

Comatose, OHCA with STEMI

62

Cold NS infusion and external cooling

33°C

24 hours

Survival and neurological outcome at discharge #

Bleeding complications
**

Thrombolysis, PCI

Improved neurological outcome
Non-significant reduction in infarct size

Gotberg et al., 2010 45

Prospective RCT

STEMI within 6 hrs of onset

20

Cold NS infusion and endovascular catheter

33°C

3 hours

Myocardium at risk and infarct size after 4 days ***

n/a

Primary PCI

38% reduction in infarct size normalized to myocardium at risk

RCT: randomized controlled trial, STEMI: ST elevation myocardial infarction, MI: myocardial infarction, MACE: major adverse cardiac events, VF: ventricular fibrillation, OHCA: out-of-hospital cardiac arrest, PCI: percutaneous coronary intervention, LVEF: left ventricular ejection fraction, CK-MB: creatinine kinase MB isofraction, n/a: not available or not applicable, NS: normal saline, *: infarct size measured by Tc-99 sestamibi SPECT imaging, †: infarct size measured by degree of CK-MB elevation, ‡: posthoc or sub-group analysis, #: neurological outcome assessed by Pittsburgh Cerebral Performance Category, **: defined as any clinically overt blood loss, ***: assessed by cardiac magnetic resonance imaging.
Table 2: Human studies analyzing hypothermia effects in AMI.